DexCom Retained Earnings increased by 8.2% to $2.63B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 54.6%, from $1.70B to $2.63B. Over 5 years (FY 2020 to FY 2025), Retained Earnings shows an upward trend with a 98.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase signals strong historical profitability and reinvestment, while a decrease may indicate losses or significant dividend payouts.
This represents the cumulative net income earned by the company since its inception, minus any dividends paid to shareho...
A key metric for all established companies; growth rates are compared against peers to gauge long-term success.
retained_earnings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$98.90M | -$28.00M | $138.70M | $236.00M | $286.90M | $388.10M | $479.90M | $528.50M | $644.40M | $765.10M | $1.02B | $1.17B | $1.31B | $1.45B | $1.60B | $1.70B | $1.88B | $2.17B | $2.43B | $2.63B |
| QoQ Change | — | +71.7% | +595.4% | +70.2% | +21.6% | +35.3% | +23.7% | +10.1% | +21.9% | +18.7% | +33.5% | +14.3% | +12.3% | +10.3% | +10.5% | +6.6% | +10.6% | +15.1% | +12.3% | +8.2% |
| YoY Change | — | — | — | — | +390.1% | >999% | +246.0% | +123.9% | +124.6% | +97.1% | +112.8% | +121.0% | +103.5% | +89.0% | +56.4% | +45.8% | +43.6% | +49.8% | +52.3% | +54.6% |